University of Michigan Engineers Develop Protein Nanoparticles to Deliver Gene Therapy Without the Risks of Viral Vectors
University of Michigan researchers develop protein-based nanoparticles that genetically modify human cells without the side effects of viral vectors.
By: AXL Media
Published: Mar 31, 2026, 4:22 AM EDT
Source: Information for this report was sourced from University of Michigan
HEADLINE
University of Michigan Engineers Develop Protein Nanoparticles to Deliver Gene Therapy Without the Risks of Viral Vectors
SUMMARY
Researchers at the University of Michigan have successfully used protein-based nanoparticles to genetically modify human liver, kidney, and immune cells. This "artificial virus" alternative aims to treat cancers and genetic diseases without the dangerous side effects associated with modified viruses or lipid-based delivery systems, such as secondary cancers or systemic inflammation.
CONTENT
A Safer Vehicle for Genetic Medicine
Categories
Topics
Related Coverage
- Whitehead Institute Researchers Re-engineer Human Producer Cells to Enhance Potency of Gene Editing Delivery Vehicles
- Wake Forest Scientists Identify Shared Genetic Blueprint for Limb Regeneration Across Axolotls, Fish, and Mice
- Virica Biotech and FUJIFILM Biosciences Partner to Scalably Boost Viral Vector Yields for Gene Therapies
- University of Michigan Engineers Develop "Trojan Horse" Starch Nanoparticles to Deliver Antibacterial Copper Directly to Drug-Resistant Biofilms